MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s43856-026-01662-y

Медицинская библиотека · Communications medicine · 2026

Genotype-specific digital twins for arrhythmia ablation targeting in arrhythmogenic right ventricular cardiomyopathy.

Zhang Yingnan, Prakosa Adityo, Zhang Kelly, Carrick Richard, Chrispin Jonathan, Zimmerman Stefan L, Aronis Konstantinos, Kholmovski Eugene G, Tichnell Crystal, Murray Brittney, James Cynthia, Calkins Hugh, Trayanova Natalia A

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a severe genetic heart disease that predominantly affects young athletic individuals and carries a high risk of ventricular tachycardia (VT) and sudden cardiac death. Catheter-based radiofrequency ablation is the state-of-the-art treatment for VT; however, its effectiveness in ARVC is limited by high recurrence rates. This study aims to develop a personalized approach to improve ablation outcomes in ARVC.

METHODS

We developed a non-invasive digital twin-based framework, termed GenDIRECT, that simulates cardiac electrical activity on patient-specific heart models to predict the optimal VT ablation targets. This retrospective study included 30 patients with ARVC of two common ARVC genotypes (GE and PKP2). Among them, 25 underwent a single clinical ablation, and 5 had repeat ablation within 12 months of the initial ablation. Predicted targets were compared with clinically delivered ablation lesions in patients who underwent initial and/or repeat procedures.

RESULTS

Here, we show that GenDIRECT-predicted ablation targets closely align with clinical ablation lesions (Dice score = 89.47%) in patients with successful initial procedures (n = 25) and are associated with significantly smaller lesion volumes (p = 5.39*10-5). In patients with VT recurrence requiring repeat procedures (n = 5), predicted targets correspond to the combined lesions from both initial and repeat ablations. GenDIRECT-guided ablation targets eliminate VT inducibility in all simulations.

CONCLUSIONS

GenDIRECT has the potential to guide clinical VT ablation procedures in ARVC by identifying comprehensive patient-specific targets. This approach may improve procedural efficacy, reduce arrhythmia recurrence, and decrease the need for repeat ablation and subsequent hospitalizations.

Для цитирования: Zhang Yingnan, Prakosa Adityo, Zhang Kelly, Carrick Richard, Chrispin Jonathan, Zimmerman Stefan L, Aronis Konstantinos, Kholmovski Eugene G, Tichnell Crystal, Murray Brittney, James Cynthia, Calkins Hugh, Trayanova Natalia A. Genotype-specific digital twins for arrhythmia ablation targeting in arrhythmogenic right ventricular cardiomyopathy.. Communications medicine. 2026. DOI: 10.1038/s43856-026-01662-y.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.